Cheng R, Tang X, Zhao Q, Wang Y, Chen W, Wang G
Research (Wash D C). 2025; 8():0578.
PMID: 39810853
PMC: 11731779.
DOI: 10.34133/research.0578.
Srichomchey P, Sukprasert S, Khulasittijinda N, Voravud N, Sahakitrungruang C, Lumjiaktase P
In Vivo. 2023; 37(1):286-293.
PMID: 36593062
PMC: 9843780.
DOI: 10.21873/invivo.13078.
Pantel K, Alix-Panabieres C
J Immunother Cancer. 2022; 10(12).
PMID: 36517082
PMC: 9756199.
DOI: 10.1136/jitc-2022-005615.
Riaz F, Wei P, Pan F
Front Cell Dev Biol. 2022; 10:949603.
PMID: 35912096
PMC: 9337771.
DOI: 10.3389/fcell.2022.949603.
Liu H, Gao H, Chen C, Jia W, Xu D, Jiang G
Front Oncol. 2022; 12:904229.
PMID: 35875081
PMC: 9303008.
DOI: 10.3389/fonc.2022.904229.
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.
Reid E, Shimabukuro K, Moore P, Ambinder R, Bui J, Han S
Clin Cancer Res. 2022; 28(12):2646-2656.
PMID: 35247913
PMC: 9197984.
DOI: 10.1158/1078-0432.CCR-21-0645.
Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma.
Pyo J, Son B, Lee H, Oh I, Chung K
Curr Oncol. 2021; 28(6):4367-4376.
PMID: 34898543
PMC: 8628731.
DOI: 10.3390/curroncol28060371.
Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer.
Liu J, Wang X, Deng Y, Yu X, Wang H, Li Z
Front Oncol. 2021; 11:766248.
PMID: 34868991
PMC: 8636122.
DOI: 10.3389/fonc.2021.766248.
The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis.
Hu L, Zhu M, Shen Y, Zhong Z, Wu B
World J Surg Oncol. 2021; 19(1):300.
PMID: 34654443
PMC: 8520308.
DOI: 10.1186/s12957-021-02420-1.
Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis.
Shi X, Li Q, Wang Y
Medicine (Baltimore). 2021; 100(3):e23957.
PMID: 33545975
PMC: 7837976.
DOI: 10.1097/MD.0000000000023957.
Human regulatory T cells (Treg) and their response to cancer.
Whiteside T
Expert Rev Precis Med Drug Dev. 2020; 4(4):215-228.
PMID: 32953989
PMC: 7500484.
DOI: 10.1080/23808993.2019.1634471.
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses.
Labani-Motlagh A, Ashja-Mahdavi M, Loskog A
Front Immunol. 2020; 11:940.
PMID: 32499786
PMC: 7243284.
DOI: 10.3389/fimmu.2020.00940.
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.
Abolarinwa B, Ibrahim R, Huang Y
Int J Mol Sci. 2019; 20(18).
PMID: 31540435
PMC: 6769557.
DOI: 10.3390/ijms20184624.
Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes and .
Wang W, Zhang Z, Li P, Ma J, Chen L, Qian H
Cancer Biol Ther. 2019; 20(9):1187-1194.
PMID: 31018748
PMC: 6741571.
DOI: 10.1080/15384047.2019.1599663.
A mathematical solution to Peto's paradox using Polya's urn model: implications for the aetiology of cancer in general.
Salazar-Banuelos A
Theory Biosci. 2019; 138(2):241-250.
PMID: 30771154
PMC: 6800849.
DOI: 10.1007/s12064-019-00290-6.
Lack of MHC class II molecules favors CD8 T-cell infiltration into tumors associated with an increased control of tumor growth.
Chaoul N, Tang A, Desrues B, Oberkampf M, Fayolle C, Ladant D
Oncoimmunology. 2018; 7(3):e1404213.
PMID: 29399403
PMC: 5790350.
DOI: 10.1080/2162402X.2017.1404213.
The Different Functional Distribution of "Not Effector" T Cells (Treg/Tnull) in Colorectal Cancer.
Niccolai E, Ricci F, Russo E, Nannini G, Emmi G, Taddei A
Front Immunol. 2018; 8:1900.
PMID: 29375559
PMC: 5770731.
DOI: 10.3389/fimmu.2017.01900.
Contribution of Adipose Tissue to Development of Cancer.
Cozzo A, Fuller A, Makowski L
Compr Physiol. 2018; 8(1):237-282.
PMID: 29357128
PMC: 5806627.
DOI: 10.1002/cphy.c170008.
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.
de Bruin R, Veluchamy J, Lougheed S, Schneiders F, Lopez-Lastra S, Lameris R
Oncoimmunology. 2018; 7(1):e1375641.
PMID: 29296532
PMC: 5739573.
DOI: 10.1080/2162402X.2017.1375641.
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
Chew V, Lai L, Pan L, Lim C, Li J, Ong R
Proc Natl Acad Sci U S A. 2017; 114(29):E5900-E5909.
PMID: 28674001
PMC: 5530700.
DOI: 10.1073/pnas.1706559114.